Katelyn E Heimbruch (Katelyn Heimbruch)

Years Active: 2022-2022
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Lauren Pommert, Eric S Schafer, Jemily Malvar, Nathan Gossai, Ellynore Florendo, Kirthi Pulakanti, Katelyn E Heimbruch, Cary Stelloh, Yueh-Yun Chi, Richard Sposto, Sridhar Rao, Van Thu Huynh, Patrick Brown, Bill H Chang, Susan I Colace, Michelle L Hermiston, Kenneth Heym, Raymond J Hutchinson, Joel A Kaplan, Rajen Mody, Tracey A O'Brien, Andrew E Place, Peter H Shaw, David S Ziegler, Alan Wayne, Deepa Bhojwani, Michael J Burke
Decitabine and vorinostat with FLAG chemotherapy in pediatric relapsed/refractory AML: Report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium. American journal of hematology 97 (5) (2022)
Alison E Meyer, Cary Stelloh, Kirthi Pulakanti, Robert Burns, Joseph B Fisher, Katelyn E Heimbruch, Sergey Tarima, Quinlan Furumo, John Brennan, Yongwei Zheng, Aaron D Viny, George S Vassiliou, Sridhar Rao
Combinatorial genetics reveals the Dock1-Rac2 axis as a potential target for the treatment of NPM1;Cohesin mutated AML. Leukemia 36 (8) (2022)

Katelyn E Heimbruch.css-eqlu8i{font-size:small;padding-left:4px;} (Katelyn Heimbruch)